DEF 14A

Proxy Statement

abrdn Life Sciences Investors Filed 2016-04-18 Acc 0001104659-16-112092

Documents 1

DEF 14A Proxy Statement , a16-5333_1def14a.htm

Around this filing

2017-04-18 DEF 14A Proxy Statement
2016-04-18 DEF 14A Proxy Statement
2016-04-18 CORRESP Correspondence Between Filers and SEC Staff
2015-04-20 DEF 14A Proxy Statement

Link to a passage

External

SEC EDGAR (opens in new tab)